These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 11170226

  • 1. Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers.
    Iyamu EW, Fasold H, Roa D, del Pilar Aguinaga M, Asakura T, Turner EA.
    J Clin Lab Anal; 2001; 15(1):1-7. PubMed ID: 11170226
    [Abstract] [Full Text] [Related]

  • 2. Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro.
    Roa D, Kopsombut P, Aguinaga MP, Turner EA.
    J Clin Lab Anal; 1997; 11(4):208-13. PubMed ID: 9219062
    [Abstract] [Full Text] [Related]

  • 3. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles.
    Jana S, Strader MB, Meng F, Hicks W, Kassa T, Tarandovskiy I, De Paoli S, Simak J, Heaven MR, Belcher JD, Vercellotti GM, Alayash AI.
    JCI Insight; 2018 Nov 02; 3(21):. PubMed ID: 30385713
    [Abstract] [Full Text] [Related]

  • 4. Differences in the reaction sequences associated with drug-induced oxidation of hemoglobins E, S, A, and F.
    Macdonald VW, Charache S.
    J Lab Clin Med; 1983 Nov 02; 102(5):762-72. PubMed ID: 6195277
    [Abstract] [Full Text] [Related]

  • 5. Enhancing Effect of Hydroxyurea on Hb F in Sickle Cell Disease: Ten-Year Egyptian Experience.
    Youssry I, Abdel-Salam A, Ismail R, Bou-Fakhredin R, Mohamed Samy R, Ezz El-Deen F, Taher AT.
    Hemoglobin; 2017 Nov 02; 41(4-6):267-273. PubMed ID: 29251012
    [Abstract] [Full Text] [Related]

  • 6. Hydroxyurea has the capacity to induce damage to human erythrocytes which can be modified by radical scavengers.
    Malec J, Przybyszewski WM, Grabarczyk M, Sitarska E.
    Biochem Biophys Res Commun; 1984 Apr 30; 120(2):566-73. PubMed ID: 6732772
    [Abstract] [Full Text] [Related]

  • 7. Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.
    Hrinczenko BW, Schechter AN, Wojtkowski TL, Pannell LK, Cashon RE, Alayash AI.
    Biochem Biophys Res Commun; 2000 Sep 07; 275(3):962-7. PubMed ID: 10973828
    [Abstract] [Full Text] [Related]

  • 8. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
    Amoyal I, Goldfarb A, Fibach E.
    Hemoglobin; 2003 May 07; 27(2):77-87. PubMed ID: 12779269
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A, Troia A, Calzolari R, Scazzone C, Rigano P, Martorana A, Sacco M, Maggio A, Di Marzo R.
    Hemoglobin; 2015 May 07; 39(4):225-9. PubMed ID: 26016899
    [Abstract] [Full Text] [Related]

  • 10. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.
    Blood; 1996 Feb 01; 87(3):887-92. PubMed ID: 8562958
    [Abstract] [Full Text] [Related]

  • 11. Role of oxygen and carbon radicals in hemoglobin oxidation.
    Minetti M, Mallozzi C, Scorza G, Scott MD, Kuypers FA, Lubin BH.
    Arch Biochem Biophys; 1993 Apr 01; 302(1):233-44. PubMed ID: 8385900
    [Abstract] [Full Text] [Related]

  • 12. Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
    Almeida CB, Souza LE, Leonardo FC, Costa FT, Werneck CC, Covas DT, Costa FF, Conran N.
    Blood; 2015 Aug 06; 126(6):711-20. PubMed ID: 26019278
    [Abstract] [Full Text] [Related]

  • 13. In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.
    Huang Z, Louderback JG, King SB, Ballas SK, Kim-Shapiro DB.
    Am J Hematol; 2001 Jul 06; 67(3):151-6. PubMed ID: 11391710
    [Abstract] [Full Text] [Related]

  • 14. Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.
    Haynes J, Baliga BS, Obiako B, Ofori-Acquah S, Pace B.
    Blood; 2004 May 15; 103(10):3945-50. PubMed ID: 14764535
    [Abstract] [Full Text] [Related]

  • 15. Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.
    Al-Nood HA, Al-Khawlani MM, Al-Akwa A.
    Hemoglobin; 2011 May 15; 35(1):13-21. PubMed ID: 21250877
    [Abstract] [Full Text] [Related]

  • 16. A biochemical and biophysical characterization of recombinant mutants of fetal hemoglobin and their interaction with sickle cell hemoglobin.
    Larson SC, Fisher GW, Ho NT, Shen TJ, Ho C.
    Biochemistry; 1999 Jul 20; 38(29):9549-55. PubMed ID: 10413533
    [Abstract] [Full Text] [Related]

  • 17. Correlation of membrane lipid peroxidation with oxidation of hemoglobin variants: possibly related to the rates of hemin release.
    Chiu DT, van den Berg J, Kuypers FA, Hung IJ, Wei JS, Liu TZ.
    Free Radic Biol Med; 1996 Jul 20; 21(1):89-95. PubMed ID: 8791096
    [Abstract] [Full Text] [Related]

  • 18. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin.
    Hebbel RP, Morgan WT, Eaton JW, Hedlund BE.
    Proc Natl Acad Sci U S A; 1988 Jan 20; 85(1):237-41. PubMed ID: 3422420
    [Abstract] [Full Text] [Related]

  • 19. Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.
    Silva DG, Belini Junior E, Carrocini GC, Torres Lde S, Ricci Júnior O, Lobo CL, Bonini-Domingos CR, de Almeida EA.
    BMC Med Genet; 2013 Oct 09; 14():108. PubMed ID: 24106994
    [Abstract] [Full Text] [Related]

  • 20. Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin.
    Kim-Shapiro DB, King SB, Bonifant CL, Kolibash CP, Ballas SK.
    Biochim Biophys Acta; 1998 Mar 12; 1380(1):64-74. PubMed ID: 9545536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.